
Marilyn G. Macasiano
Examiner (ID: 2397, Phone: (571)270-5205 , Office: P/3688 )
| Most Active Art Unit | 3688 |
| Art Unit(s) | 3688, 3622 |
| Total Applications | 654 |
| Issued Applications | 347 |
| Pending Applications | 61 |
| Abandoned Applications | 258 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
| 09/914770 | Copper agonist that binds on the copper binding site of app and/or exerts an inhibiting effect on the release of amyloid abeta peptide | Jan 1, 2002 | Abandoned |
Array
(
[id] => 993518
[patent_doc_number] => 06916617
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-07-12
[patent_title] => 'Grapevine leafroll virus proteins and their uses'
[patent_app_type] => utility
[patent_app_number] => 10/039112
[patent_app_country] => US
[patent_app_date] => 2001-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 57
[patent_figures_cnt] => 60
[patent_no_of_words] => 26575
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/916/06916617.pdf
[firstpage_image] =>[orig_patent_app_number] => 10039112
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/039112 | Grapevine leafroll virus proteins and their uses | Dec 30, 2001 | Issued |
Array
(
[id] => 6782989
[patent_doc_number] => 20030064436
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-03
[patent_title] => 'Method for producing, in yeast, a hydroxylated triple helical protein, and yeast host cells useful in said method'
[patent_app_type] => new
[patent_app_number] => 10/023831
[patent_app_country] => US
[patent_app_date] => 2001-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12018
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20030064436.pdf
[firstpage_image] =>[orig_patent_app_number] => 10023831
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/023831 | Method for producing, in yeast, a hydroxylated triple helical protein, and yeast host cells useful in said method | Dec 20, 2001 | Abandoned |
Array
(
[id] => 6581498
[patent_doc_number] => 20020166134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-07
[patent_title] => 'Cardiomyocytes with enhanced proliferative potenial, and methods for preparing and using same'
[patent_app_type] => new
[patent_app_number] => 10/024066
[patent_app_country] => US
[patent_app_date] => 2001-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 11193
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20020166134.pdf
[firstpage_image] =>[orig_patent_app_number] => 10024066
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/024066 | Cardiomyocytes with enhanced proliferative potenial, and methods for preparing and using same | Dec 17, 2001 | Abandoned |
Array
(
[id] => 7617174
[patent_doc_number] => 06946266
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-09-20
[patent_title] => 'Gene transfer in chicken bursal stem cells'
[patent_app_type] => utility
[patent_app_number] => 10/025199
[patent_app_country] => US
[patent_app_date] => 2001-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13446
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/946/06946266.pdf
[firstpage_image] =>[orig_patent_app_number] => 10025199
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/025199 | Gene transfer in chicken bursal stem cells | Dec 17, 2001 | Issued |
Array
(
[id] => 6648717
[patent_doc_number] => 20030007956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-09
[patent_title] => 'Proteins that interact with betaTrCP'
[patent_app_type] => new
[patent_app_number] => 10/023530
[patent_app_country] => US
[patent_app_date] => 2001-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 17947
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0007/20030007956.pdf
[firstpage_image] =>[orig_patent_app_number] => 10023530
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/023530 | Proteins that interact with betaTrCP | Dec 17, 2001 | Abandoned |
Array
(
[id] => 7221417
[patent_doc_number] => 20040072352
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-15
[patent_title] => 'Expression vector for animal cell containing nuclear matrix attachment region of interferon beta'
[patent_app_type] => new
[patent_app_number] => 10/450556
[patent_app_country] => US
[patent_app_date] => 2003-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 5359
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20040072352.pdf
[firstpage_image] =>[orig_patent_app_number] => 10450556
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/450556 | Expression vector for animal cell containing nuclear matrix attachment region of interferon beta | Dec 13, 2001 | Issued |
Array
(
[id] => 972043
[patent_doc_number] => 06936428
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-08-30
[patent_title] => 'Dimeric flourescent polypeptides'
[patent_app_type] => utility
[patent_app_number] => 10/021818
[patent_app_country] => US
[patent_app_date] => 2001-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 14739
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/936/06936428.pdf
[firstpage_image] =>[orig_patent_app_number] => 10021818
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/021818 | Dimeric flourescent polypeptides | Dec 12, 2001 | Issued |
Array
(
[id] => 6567519
[patent_doc_number] => 20020112256
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-15
[patent_title] => 'Transgenic mice containing proliferator-activated receptor gene disruptions'
[patent_app_type] => new
[patent_app_number] => 10/013807
[patent_app_country] => US
[patent_app_date] => 2001-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 19993
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20020112256.pdf
[firstpage_image] =>[orig_patent_app_number] => 10013807
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/013807 | Transgenic mice containing proliferator-activated receptor gene disruptions | Dec 10, 2001 | Abandoned |
Array
(
[id] => 1290707
[patent_doc_number] => 06630321
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-10-07
[patent_title] => 'Method for identifying a compound that modulates the function of the gene product of an essential gene'
[patent_app_type] => B1
[patent_app_number] => 09/980686
[patent_app_country] => US
[patent_app_date] => 2001-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 2953
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/630/06630321.pdf
[firstpage_image] =>[orig_patent_app_number] => 09980686
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/980686 | Method for identifying a compound that modulates the function of the gene product of an essential gene | Dec 6, 2001 | Issued |
Array
(
[id] => 6763266
[patent_doc_number] => 20030126628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-03
[patent_title] => 'Ovomucoid promoter and methods of use'
[patent_app_type] => new
[patent_app_number] => 09/998716
[patent_app_country] => US
[patent_app_date] => 2001-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13667
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0126/20030126628.pdf
[firstpage_image] =>[orig_patent_app_number] => 09998716
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/998716 | Ovomucoid promoter and methods of use | Nov 29, 2001 | Issued |
Array
(
[id] => 6846684
[patent_doc_number] => 20030165851
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Novel polypetides and nucleic acids encoding same'
[patent_app_type] => new
[patent_app_number] => 09/997425
[patent_app_country] => US
[patent_app_date] => 2001-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52092
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20030165851.pdf
[firstpage_image] =>[orig_patent_app_number] => 09997425
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/997425 | Novel polypetides and nucleic acids encoding same | Nov 28, 2001 | Abandoned |
Array
(
[id] => 6746823
[patent_doc_number] => 20030024006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-30
[patent_title] => 'Gene switches'
[patent_app_type] => new
[patent_app_number] => 09/995973
[patent_app_country] => US
[patent_app_date] => 2001-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 32100
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0024/20030024006.pdf
[firstpage_image] =>[orig_patent_app_number] => 09995973
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/995973 | Gene switches | Nov 27, 2001 | Issued |
Array
(
[id] => 6047993
[patent_doc_number] => 20020168750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-14
[patent_title] => 'Enzymatically active recombinant glucocerebrosidase'
[patent_app_type] => new
[patent_app_number] => 09/995337
[patent_app_country] => US
[patent_app_date] => 2001-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 7494
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0168/20020168750.pdf
[firstpage_image] =>[orig_patent_app_number] => 09995337
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/995337 | Enzymatically active recombinant glucocerebrosidase | Nov 26, 2001 | Abandoned |
Array
(
[id] => 1391629
[patent_doc_number] => 06548656
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-15
[patent_title] => 'Frame adjust linkers'
[patent_app_type] => B1
[patent_app_number] => 09/914445
[patent_app_country] => US
[patent_app_date] => 2001-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 1840
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/548/06548656.pdf
[firstpage_image] =>[orig_patent_app_number] => 09914445
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/914445 | Frame adjust linkers | Nov 25, 2001 | Issued |
Array
(
[id] => 6683230
[patent_doc_number] => 20030119094
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'Solubility reporter gene constructs'
[patent_app_type] => new
[patent_app_number] => 09/990099
[patent_app_country] => US
[patent_app_date] => 2001-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 15429
[patent_no_of_claims] => 76
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20030119094.pdf
[firstpage_image] =>[orig_patent_app_number] => 09990099
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/990099 | Solubility reporter gene constructs | Nov 20, 2001 | Abandoned |
Array
(
[id] => 1212525
[patent_doc_number] => 06709861
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-03-23
[patent_title] => 'Cloning vectors and vector components'
[patent_app_type] => B2
[patent_app_number] => 10/001052
[patent_app_country] => US
[patent_app_date] => 2001-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 46009
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/709/06709861.pdf
[firstpage_image] =>[orig_patent_app_number] => 10001052
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/001052 | Cloning vectors and vector components | Nov 14, 2001 | Issued |
Array
(
[id] => 6567980
[patent_doc_number] => 20020165183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-07
[patent_title] => 'Methods for genetic immunization'
[patent_app_type] => new
[patent_app_number] => 09/992957
[patent_app_country] => US
[patent_app_date] => 2001-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 17840
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20020165183.pdf
[firstpage_image] =>[orig_patent_app_number] => 09992957
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/992957 | Methods for genetic immunization | Nov 12, 2001 | Abandoned |
Array
(
[id] => 6687956
[patent_doc_number] => 20030031681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-13
[patent_title] => 'Combined growth factor-deleted and thymidine kinase-deleted vaccinia virus vector'
[patent_app_type] => new
[patent_app_number] => 09/991721
[patent_app_country] => US
[patent_app_date] => 2001-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 26151
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20030031681.pdf
[firstpage_image] =>[orig_patent_app_number] => 09991721
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/991721 | Combined growth factor-deleted and thymidine kinase-deleted vaccinia virus vector | Nov 12, 2001 | Issued |
Array
(
[id] => 7467896
[patent_doc_number] => 20040053879
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-18
[patent_title] => 'Use of the human lrp/mvp promotor for a vector that can be induced by therapy'
[patent_app_type] => new
[patent_app_number] => 10/416209
[patent_app_country] => US
[patent_app_date] => 2003-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 1192
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20040053879.pdf
[firstpage_image] =>[orig_patent_app_number] => 10416209
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/416209 | Use of the human LRP/MVP promotor for a vector that can be induced by therapy | Nov 7, 2001 | Issued |